ストックスクリーナーアプリを入手
1.85
7.50%
-0.15
プレマーケット:
1.83
-0.02
-1.08%
Palisade Bio Inc (PALI) 最新ニュース
How moving averages guide Palisade Bio Inc. tradingMarket Trend Report & Growth Oriented Trading Recommendations - newser.com
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 - GlobeNewswire
What’s next for Palisade Bio Inc. stock pricePortfolio Gains Report & Risk Managed Investment Strategies - newser.com
Should I hold or sell Palisade Bio Inc. stock in 2025Wall Street Watch & Verified Momentum Watchlists - newser.com
Price action breakdown for Palisade Bio Inc.July 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Is Palisade Bio Inc. showing signs of accumulation2025 Volume Leaders & Growth Focused Entry Reports - newser.com
Palisade Bio Receives Canadian Patent for Composition of Product Candidate PALI-2108 - MarketScreener
Sector ETF performance correlation with Palisade Bio Inc.July 2025 Action & Risk Managed Trade Strategies - newser.com
Palisade Bio receives Canadian patent for inflammatory bowel drug - Investing.com
Palisade Bio Announces Grant of Patent for PALI-2108, a First-in-Class PDE4 Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis - Quiver Quantitative
PALI-2108 patent No. 3,174,137 protects drug through May 28, 2041 — Palisade Bio targets FSCD & UC - Stock Titan
Using data filters to optimize entry into Palisade Bio Inc.2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
What MACD and RSI say about Palisade Bio Inc.Treasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
Will Palisade Bio Inc. stock recover after recent dropJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
What analysts say about Palisade Bio Inc stockResistance Breakout Alerts & Rapid Portfolio Strategies - earlytimes.in
Palisade Bio Inc. stock trend outlook and recovery pathWeekly Market Report & Weekly High Conviction Trade Ideas - newser.com
Is Palisade Bio Inc. stock dividend yield sustainableMarket Rally & Free Community Supported Trade Ideas - newser.com
Palisade Bio, Inc. Cancels Special Meeting of Stockholders - TradingView
Palisade Bio Announces Cancellation of Special Meeting of Stockholders - GlobeNewswire
Special Meeting Cancelled: Palisade Bio Withdraws Proxy Proposals After Failing to Secure Quorum - Stock Titan
Cohen's Point72 Pours $14M in This Biotech Stock That… - inkl
Statistical indicators supporting Palisade Bio Inc.’s strengthMarket Trend Summary & Stepwise Swing Trade Plans - newser.com
How to forecast Palisade Bio Inc. trends using time seriesRate Cut & Reliable Intraday Trade Alerts - newser.com
Why Palisade Bio Inc. (7NS0) stock could outperform next yearJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Ranking Palisade Bio Inc. among high performing stocks via toolsInsider Buying & Breakout Confirmation Trade Signals - newser.com
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews
Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut - Benzinga
Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq
Is It Too Late to Buy Palisade Bio? - StocksToTrade
Palisade Bio Launches Phantom Unit Plan for Employees - MSN
Palisade Bio Stock Climbs To 9-Month High After $120M Stock Offering; Retail Sees More Gains Ahead - MSN
Morning Market Movers: FEMY, PALI, COSM, Seeing Big Swings - RTTNews
Morning Market Movers: SOPA, CRML, SANM, PALI See Big Swings - RTTNews
Is Palisade Bio Inc. stock bottoming outMarket Trend Report & Intraday High Probability Setup Alerts - newser.com
Understanding Palisade Bio Inc.’s price movementJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Can Palisade Bio Inc. (7NS0) stock sustain breakout momentumJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com
Can technical indicators confirm Palisade Bio Inc.’s reversalJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Palisade Bio: Can It Balance the Volatility? - StocksToTrade
Published on: 2025-10-03 04:14:10 - newser.com
Using economic indicators to assess Palisade Bio Inc. potentialWeekly Profit Analysis & Weekly High Return Forecasts - newser.com
Published on: 2025-10-03 02:59:00 - newser.com
Palisade Bio (PALI) Stock Soars 30% on Securing $138M Public Offering Backed by Top Healthcare Players - parameter.io
Palisade Bio closes $138 million public offering for IBD drug development - Investing.com Nigeria
What technical patterns form on Palisade Bio Inc. (7NS0) stock charts2025 Big Picture & Daily Stock Trend Watchlist - newser.com
Palisade Bio closes $138 million public offering for IBD drug development By Investing.com - Investing.com South Africa
Palisade Bio Closes $138 Million Public Offering to Advance PALI-2108 for Ulcerative Colitis Development - Quiver Quantitative
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option - The Manila Times
1.11%
大文字化:
|
ボリューム (24 時間):